Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BEYFORTUS™ safely and effectively. See full prescribing information for BEYFORTUS.BEYFORTUS (nirsevimab-alip) injection, for intramuscular useInitial U.S. Approval: 2023
Medication labelWhy this: Advisory · dailymed-prescription
BEYFORTUS is indicated for the prevention of Respiratory Syncytial Virus (RSV) lower respiratory tract disease in: •Neonates and infants born during or entering their first RSV season. •Children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season.
- generic_name
- nirsevimab
- product_names
- nirsevimab
- ndc
- 49281-575, 49281-575-00, 49281-575-15, 49281-574, 49281-574-88, 49281-574-15
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en